Astrazeneca (AZN) said Thursday it will invest CA$820 million ($570 million) in Canada and create over 700 high-skilled jobs across its operations in the country.
The investment includes moving to a larger facility to Greater Toronto Area in Ontario, the company said.
This initiative will support AstraZeneca's $80 billion global revenue goal by 2030 and its plan to launch 20 new medicines within the same timeframe, it added.
The company said it expects seven phase 3 clinical trial data readouts this year.
Price: 68.49, Change: +0.28, Percent Change: +0.42
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。